UB researchers develop new inhalable treatment for TB: Study Dr. Kamal Kant Kohli23 Feb 2026 8:30 PM ISTResearchers at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo have developed a new inhalable form of tuberculosis...
Medical Bulletin 16/February/2026 Anshika Mishra16 Feb 2026 3:00 PM ISTHere are the top medical news for today:Shorter TB Regimens Reduce Costs in India: ICMR Study Six-month, all-oral treatment regimens for...
Shorter TB Regimens Reduce Costs in India: ICMR Study Anshika Mishra16 Feb 2026 8:00 AM ISTSix-month, all-oral treatment regimens for multidrug-resistant and rifampicin-resistant tuberculosis (MDR/RR-TB) are both cost-effective and...
ICMR Study shows shorter TB regimes are cost-effective in India Kajal Rajput13 Feb 2026 3:14 PM ISTNew Delhi: Six-month all-oral treatment regimens for multidrug-resistant and rifampicin-resistant tuberculosis (MDR/RR-TB) in India are not only...
Early TB treatment reduced deaths from sepsis among people with HIV: Lancet Dr. Kamal Kant Kohli12 Feb 2026 8:15 PM ISTSepsis is a leading global cause of hospital deaths, occurring when the body’s response to infection damages tissue and causes organs to fail. Africa...
Lupin Partners with TB Alliance to Advance Telacebec for TB, Leprosy and Buruli Ulcer sheeba farhat2 Feb 2026 5:40 PM ISTMumbai: Pharma major Lupin Limited has announced a strategic collaboration with TB Alliance, a nonprofit drug developer, to advance the clinical...
Mission-Mode Approach for Drug Regulation and TB Mukt Bharat key priorities: JP Nadda Kajal Rajput30 Dec 2025 3:00 PM ISTNew Delhi: Union Minister of Health & Family Welfare, Shri JP Nadda, yesterday convened a high-level review meeting with the Health Minister and...
Health Minister stresses patient-centric care, drug regulation in review with MP and Chhattisgarh Kajal Rajput27 Dec 2025 5:03 PM ISTNew Delhi: The Union Minister of Health & Family Welfare, Shri Jagat Prakash Nadda, yesterday chaired a high-level review meeting with the Health...
Bharat Biotech, Biofabri ink technology transfer deal for TB vaccine MTBVAC Ruchika Sharma23 Dec 2025 4:30 PM ISTHyderabad: Biofabri, a global human vaccine development company that is part of the Zendal group, and Bharat Biotech International Limited...
India Reports 21 Percent Decline in TB Cases Since 2015, Treatment Coverage Rises to 92%: MoS Health Anshika Mishra20 Dec 2025 6:15 PM ISTAccording to the World Health Organisation (WHO) Global TB Report 2025, India has made good progress in controlling tuberculosis. The number of TB...
Health Bulletin 20/December/2025 Anshika Mishra20 Dec 2025 5:27 PM ISTHere are the top health stories for the day:NMC approves 7,619 new PG medical seats, totalling 57,503 for 2025–26The Medical Assessment and Rating...
TB cases in India decline by 21 percent: MoS Health tells Rajya Sabha Adity Saha20 Dec 2025 9:45 AM ISTNew Delhi: According to the World Health Organisation (WHO) Global TB Report 2025, India has made good progress in controlling tuberculosis. The...
